Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Goos

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Molecular Imaging and Biology|February 17, 2022
Correction: Optimisation of the Synthesis and Cell Labelling Conditions for [89Zr]Zr-oxine and [89Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic ApplicationsIda Friberger, Emma Jussing, Jinming Han, et al.
Nuclear Medicine and Biology|March 6, 2020
Design and preclinical evaluation of nanostars for the passive pretargeting of tumor tissueJeroen A C M Goos, Maria Davydova, Thomas R Dilling, et al.
Oncoimmunology|October 26, 2020
Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosisSandrine Nugteren, Jeroen A C M Goos, Pien M Delis-van Diemen, et al.
Theranostics|January 7, 2020
Delivery of polymeric nanostars for molecular imaging and endoradiotherapy through the enhanced permeability and retention (EPR) effectJeroen A C M Goos, Andrew Cho, Lukas M Carter, et al.
Oncogene|August 27, 2013
The role of KCNQ1 in mouse and human gastrointestinal cancersB L N Than, J A C M Goos, A L Sarver, et al.
Nuclear Medicine and Biology|October 4, 2015
Molecular imaging of aurora kinase A (AURKA) expression: Synthesis and preclinical evaluation of radiolabeled alisertib (MLN8237)Jeroen A C M Goos, Joost Verbeek, Albert A Geldof, et al.
British Journal of Cancer|October 10, 2013
Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosisJ A C M Goos, V M H Coupe, B Diosdado, et al.
British Journal of Cancer|July 2, 2014
Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastasesJ A C M Goos, A C Hiemstra, V M H Coupé, et al.
Annals of Surgery|January 8, 2015
Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver MetastasisJeroen A C M Goos, Erienne M V de Cuba, Veerle M H Coupé, et al.
Oncotarget|October 27, 2015
A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9Jeroen A C M Goos, Veerle M H Coupé, Mark A van de Wiel, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Molecular Imaging and Biology|February 17, 2022
Correction: Optimisation of the Synthesis and Cell Labelling Conditions for [89Zr]Zr-oxine and [89Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic ApplicationsIda Friberger, Emma Jussing, Jinming Han, et al.
Nuclear Medicine and Biology|March 6, 2020
Design and preclinical evaluation of nanostars for the passive pretargeting of tumor tissueJeroen A C M Goos, Maria Davydova, Thomas R Dilling, et al.
Oncoimmunology|October 26, 2020
Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosisSandrine Nugteren, Jeroen A C M Goos, Pien M Delis-van Diemen, et al.
Theranostics|January 7, 2020
Delivery of polymeric nanostars for molecular imaging and endoradiotherapy through the enhanced permeability and retention (EPR) effectJeroen A C M Goos, Andrew Cho, Lukas M Carter, et al.
Oncogene|August 27, 2013
The role of KCNQ1 in mouse and human gastrointestinal cancersB L N Than, J A C M Goos, A L Sarver, et al.
Nuclear Medicine and Biology|October 4, 2015
Molecular imaging of aurora kinase A (AURKA) expression: Synthesis and preclinical evaluation of radiolabeled alisertib (MLN8237)Jeroen A C M Goos, Joost Verbeek, Albert A Geldof, et al.
British Journal of Cancer|October 10, 2013
Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosisJ A C M Goos, V M H Coupe, B Diosdado, et al.
British Journal of Cancer|July 2, 2014
Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastasesJ A C M Goos, A C Hiemstra, V M H Coupé, et al.
Annals of Surgery|January 8, 2015
Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver MetastasisJeroen A C M Goos, Erienne M V de Cuba, Veerle M H Coupé, et al.
Oncotarget|October 27, 2015
A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9Jeroen A C M Goos, Veerle M H Coupé, Mark A van de Wiel, et al.
Pageof 5